Mounjaro and Zepbound no longer in shortage
Source: @BreaknNews
USA TODAY - For more and to sign up click here Joseph Choi After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and obesity medications Mounjaro and Zepbound, was declared in shortage in December 2022. The shortage has been attributed to increased demand as interest in GLP-1…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at @BreaknNews